Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Elite Pharmaceuticals Inc ELTP
Posted On: 02/15/2013 10:52:56 AM
Post# of 2146
Avatar
Posted By: AJM16w

Financial overview of Q3\2013


The third quarter of fiscal year 2013 saw $668K in revenue. This is an increase of $34K, or 5% in revenues from the previous quarter.


The cost of revenues saw a significant decline of $-212, or -44% for a total of gross profit of $401K.


This quarter’s operating expenses totaled $675, leaving Elite with a net loss from operations of -$274K, which is a decline of -47% from the previous quarter.


 


Revenue


Manufacturing revenue which totaled $400K saw a decline of -$66K, or -14% from the previous quarter.


Compared with the previous quarter, royalty and Lic revenue which totaled $157K grew by $3K, or 2%.


Lab fees which totaled $111K increased significantly from the previous quarter by 693%, or $97K.


 


YOY comparison


Compared to Q3\2012, Elite generated an additional $159K in revenues, for growth of 31%.


YTD revenues total $1,880K which compared to last year is an increase of 6%.


 


Source: 2011, 2012, and 2013 SEC Form 10-Q available at http://www.sec.gov/search/search.htm














(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site